没有排水与经过穿孔性胃潰瘍修复后的排水:一个随机控制的循环
Mohammed Elshwadfy Nageeb1, Wael Tobar2, Ahmed Saqr2
1Cairo University, Cairo, Egypt. mohammedelshwadfy@kasralainy.edu.eg.
概括
穿孔性胃潰瘍修復后省略腹腔排水是安全的,並改善患者的康復. 这种方法导致住院时间缩短,并发症减少,改善整体结果.
科学领域:
- 手术创新 在外科创新.
- 胃肠道手术 胃肠道手术
- 临床试验 临床试验
背景情况:
- 穿孔性胃潰瘍疾病需要手術干預.
- 腹腔内排水传统上用于修复后管理并发症.
- 关于特定外科手术中排水的必要性的证据正在不断发展.
研究的目的:
- 评估穿孔性胃潰瘍修復后省略腹腔下水道的安全性和有效性.
- 为了比较患者的康复参数和患病率在有排水和没有排水的组之间.
主要方法:
- 一项前性随机对照试验,涉及有穿孔性胃潰瘍的患者.
- 患者被随机分为两个组:一个有腹内排水,一个没有.
- 主要结局:住院时间 (LOS);次要结局:康复参数和30天的发病率.
主要成果:
- 没有排水的小组表现出显著更早的肠道排便,液体/固体饮食摄入量,疼痛减少.
- 没有排水组的患者在医院住院时间较短 (4.74天而不是5.75天).
- 在没有排水组中观察到明显较低的发病率,包括手术部位感染和呼吸道并发症.
结论:
- 在穿孔性胃潰瘍修復後省略腹腔下水道是安全的做法.
- 疏通疏通可以改善患者的康复和减少并发症.
- 这一策略为这种患者群体的手术结果提供了潜在的增强.
更多相关视频
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
287
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
287
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Appendicitis-II: Diagnostic Studies and Management
74
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
74
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
403
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
403
Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162


